Skip to main content
Focused investors/John Armitage

John Armitage - Egerton Capital

As of Q2 2026, John Armitage reported 23 long-equity positions worth $10.35B in aggregate.

Copy-investor backtest

Latest quarter
+2.23%
1-year
+10.55%
3-year
+60.98%
5-year
+47.81%
3-year vs S&P 500
-6.84%
5-year vs S&P 500
-20.31%
5-year top 5
+13.02%

Return from mechanically copying the disclosed 13F equity portfolio after each filing and rebalancing at the next. The vs S&P 500 figures subtract SPY over that manager's own rebalance dates, so both sides cover the same days; both are price return, excluding dividends. Method & limitations.

Get email alerts when John Armitage files a new 13F — sign in or create a free account.

Sells

These are the positions the manager reduced or sold out of this quarter, showing where they pulled money back. The quarter shown is Q2 2026.

TickerSecurityActivity% portfolioSharesValueReported priceQ range
LINLINDE PLCReduce -71.8%1.51%300,854$156.13M$518.94$482.77 - $527.94(80%)$493.83 -> $518.94
IBKRINTERACTIVE BROKERS GROUP INReduce -34.2%3.47%4,129,416$359.42M$87.04$65.40 - $97.83(67%)$67.91 -> $87.04
UBERUBER TECHNOLOGIES INCReduce -50.1%1.62%2,319,648$167.39M$72.16$67.19 - $80.83(36%)$71.71 -> $72.16
ACGLARCH CAP GROUP LTDSold0$0-
CNQCANADIAN NAT RES LTD MED TERSold0$0-
CRSCARPENTER TECHNOLOGY CORPSold0$0-
CMECME GROUP INCSold0$0-
NYTNEW YORK TIMES CO MTN BESold0$0-
RNRRENAISSANCERE HLDGS LTDSold0$0-
GOOGALPHABET INCReduce -4.9%11.24%3,291,594$1.16B$353.33$287.57 - $404.47(56%)$294.90 -> $353.33
MAMASTERCARD INCORPORATEDReduce -20.9%1.80%363,490$186.69M$513.60$464.52 - $534.21(70%)$491.65 -> $513.60